Yangyang Meng

407 total citations
28 papers, 292 citations indexed

About

Yangyang Meng is a scholar working on Molecular Biology, Gastroenterology and Physiology. According to data from OpenAlex, Yangyang Meng has authored 28 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Gastroenterology and 6 papers in Physiology. Recurrent topics in Yangyang Meng's work include Gastrointestinal motility and disorders (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Diet and metabolism studies (4 papers). Yangyang Meng is often cited by papers focused on Gastrointestinal motility and disorders (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Diet and metabolism studies (4 papers). Yangyang Meng collaborates with scholars based in China, Finland and Australia. Yangyang Meng's co-authors include Zhong Li, Shunjie Liu, Mingze Qin, Junhao Pan, Lu He, Di Wu, Yajing Liu, Ke Tang, Yunlei Hou and Xiaodong Cai and has published in prestigious journals such as The FASEB Journal, Journal of Medicinal Chemistry and International Journal of Hydrogen Energy.

In The Last Decade

Yangyang Meng

25 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangyang Meng China 9 77 72 62 44 43 28 292
Sylvan Green United States 8 139 1.8× 112 1.6× 99 1.6× 78 1.8× 195 4.5× 8 501
Xi‐Yang Cui China 6 47 0.6× 48 0.7× 80 1.3× 44 1.0× 27 0.6× 8 274
Manxia Wang China 12 157 2.0× 22 0.3× 29 0.5× 25 0.6× 67 1.6× 53 453
Deviney M. Chaponis United States 6 209 2.7× 40 0.6× 37 0.6× 67 1.5× 21 0.5× 7 403
Murad Al‐Nusaif China 12 157 2.0× 29 0.4× 23 0.4× 5 0.1× 47 1.1× 27 320
Zhang Hq China 7 121 1.6× 42 0.6× 44 0.7× 3 0.1× 12 0.3× 35 290
Ruifang Dong China 10 212 2.8× 11 0.2× 73 1.2× 8 0.2× 64 1.5× 16 422
Kevin L. Best United States 9 72 0.9× 39 0.5× 19 0.3× 3 0.1× 9 0.2× 10 324
Haris Younas United States 7 146 1.9× 37 0.5× 40 0.6× 10 0.2× 181 4.2× 8 415

Countries citing papers authored by Yangyang Meng

Since Specialization
Citations

This map shows the geographic impact of Yangyang Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyang Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyang Meng more than expected).

Fields of papers citing papers by Yangyang Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangyang Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyang Meng. The network helps show where Yangyang Meng may publish in the future.

Co-authorship network of co-authors of Yangyang Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Yangyang Meng. A scholar is included among the top collaborators of Yangyang Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangyang Meng. Yangyang Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yuan, Yidong Wang, Jiwei Gao, et al.. (2024). The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor. EMBO Molecular Medicine. 16(4). 885–903. 5 indexed citations
2.
Zhang, Rongchao, Libo Wang, Changsheng An, et al.. (2024). Precursor-reforming protocol to hierarchical porous g-C3N4 with N defects for remarkable visible-light-driven hydrogen evolution. International Journal of Hydrogen Energy. 84. 731–738. 7 indexed citations
4.
5.
Wang, Yi, Yue Wu, Xiao Wang, et al.. (2024). Tonghua Liyan granules in the treatment of Laryngopharyngeal reflux disease with stagnation of phlegm and qi syndrome: a randomized, double-blind, placebo-controlled study. Frontiers in Pharmacology. 15. 1275740–1275740. 1 indexed citations
6.
Meng, Yangyang, Yidong Wang, Shaopeng Zhang, et al.. (2023). Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy. Journal of Medicinal Chemistry. 66(17). 11815–11830. 6 indexed citations
7.
Liu, Yajing, et al.. (2023). Agents for the Treatment of Gout: Current Advances and Future Perspectives. Journal of Medicinal Chemistry. 66(21). 14474–14493. 24 indexed citations
8.
Liu, Shunjie, et al.. (2023). Disturbance of REM sleep exacerbates microglial activation in APP/PS1 mice. Neurobiology of Learning and Memory. 200. 107737–107737. 7 indexed citations
9.
Meng, Yangyang, et al.. (2022). No synergistic effect of fecal microbiota transplantation and shugan decoction in water avoidance stress-induced IBS-D rat model. Frontiers in Microbiology. 13. 995567–995567. 4 indexed citations
10.
Liu, Shunjie, et al.. (2022). NREM sleep loss increases neurofilament light chain levels in APP/PS1 and C57BL/6 J mice. Sleep And Breathing. 27(4). 1495–1504. 5 indexed citations
11.
Meng, Yangyang, Di Wu, Lei Liu, et al.. (2022). Discovery of 4-phenylindolines containing a (5-cyanopyridin-3-yl)methoxy moiety as potent inhibitors of the PD-1/PD-L1 interaction. Bioorganic & Medicinal Chemistry Letters. 63. 128647–128647. 5 indexed citations
12.
Feng, Ya, et al.. (2022). Metagenomics and metabolomics analysis to investigate the effect of Shugan decoction on intestinal microbiota in irritable bowel syndrome rats. Frontiers in Microbiology. 13. 1024822–1024822. 8 indexed citations
13.
Qin, Mingze, Yangyang Meng, Lei Liu, et al.. (2021). Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Journal of Medicinal Chemistry. 64(9). 5519–5534. 46 indexed citations
14.
Wu, Xia, Yangyang Meng, Lei Liu, et al.. (2021). Insights into non-peptide small-molecule inhibitors of the PD-1/PD-L1 interaction: Development and perspective. Bioorganic & Medicinal Chemistry. 33. 116038–116038. 14 indexed citations
15.
Qin, Mingze, Ye Tian, Qi Cao, et al.. (2020). Structural modifications of indolinones bearing a pyrrole moiety and discovery of a multi-kinase inhibitor with potent antitumor activity. Bioorganic & Medicinal Chemistry. 28(11). 115486–115486. 8 indexed citations
16.
Liu, Shunjie, et al.. (2020). Plasma Neurofilament Light Chain May Be a Biomarker for the Inverse Association Between Cancers and Neurodegenerative Diseases. Frontiers in Aging Neuroscience. 12. 10–10. 15 indexed citations
17.
Wang, Yinshu, et al.. (2020). Shugan Decoction Alleviates Colonic Dysmotility in Female SERT-Knockout Rats by Decreasing M3 Receptor Expression. Frontiers in Pharmacology. 11. 1082–1082. 8 indexed citations
19.
Wang, Linjing, et al.. (2019). Central nervous system vasculopathy caused by Fabry disease: a case report. BMC Neurology. 19(1). 115–115. 3 indexed citations
20.
Liu, Shunjie, Junhao Pan, Ke Tang, et al.. (2019). Sleep spindles, K-complexes, limb movements and sleep stage proportions may be biomarkers for amnestic mild cognitive impairment and Alzheimer’s disease. Sleep And Breathing. 24(2). 637–651. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026